Literature DB >> 8288321

Characterization of a thyroiditis-inducing thyroglobulin-specific T-cell clone restricted by the H-2 molecule of a low responder mouse strain.

Y Hiyama1, Y Kohno, A Hoshioka, N Shimojo, O Tarutani, T Yokochi, N Maruyama, H Niimi.   

Abstract

We established a thyroglobulin (Tg)-specific, thyroiditis-inducing T-cell clone, B12G, from B6C3F1 mice by the immunization of mouse Tg with lipopolysaccharide (LPS) from Klebsiella strain LEN (O3:K1). B12G was Thy-1.2+, CD3+, CD4+, CD18+, and CD8-, and could transfer thyroiditis to recipient mice after in vitro stimulation with mouse or bovine Tg. Histological examination showed severe thyroiditis with predominant infiltrations of polymorphonuclear cells; few mononuclear cells were observed. B12G proliferated in response to bovine, mouse, porcine, and rat Tg in the presence of irradiated spleen cells, but did not respond to chicken or human Tg. H-2b, a low-responder haplotype of experimental autoimmune thyroiditis, governed the response of the clone to Tg. B12G produced interleukin-4 (IL-4) and IL-6, but not IL-2 or interferon-gamma (IFN-gamma), on stimulation with mouse Tg. These findings were different from characteristics of previously reported Tg-specific T-cell clones from high-responder mice in terms of epitope specificity and cytokine production pattern, raising the possibility that the specificities and functions of T cells involved in the development of autoimmune thyroiditis in low-responder mice differ from those in high responders.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8288321      PMCID: PMC1422206     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  20 in total

1.  Autoreactive T-cell lines specific for mouse thyroglobulin.

Authors:  B R Champion; A M Varey; D Katz; A Cooke; I M Roitt
Journal:  Immunology       Date:  1985-03       Impact factor: 7.397

2.  Characterization and sequencing of a 40-amino-acid peptide from human thyroglobulin inducing experimental autoimmune thyroiditis.

Authors:  B Texier; C Bédin; H Tang; L Camoin; C Laurent-Winter; J Charreire
Journal:  J Immunol       Date:  1992-06-01       Impact factor: 5.422

3.  Microbial adjuvant and autoimmunity. III. Histological studies of development of experimental autoimmune thyroiditis in mice immunized with syngeneic thyroid extract together with the capsular polysaccharide of Klebsiella pneumoniae.

Authors:  T Yokochi; I Nakashima; N Kato; J Asai
Journal:  Microbiol Immunol       Date:  1978       Impact factor: 1.955

4.  Familial lymphocytic thyroiditis: analysis of linkage with histocompatibility and blood groups.

Authors:  H H Bode; M E Dorf; A P Forbes
Journal:  J Clin Endocrinol Metab       Date:  1973-11       Impact factor: 5.958

5.  Autoimmune thyroiditis: conversion of low-responder mice to high-responders by cyclophosphamide.

Authors:  A O Vladutiu
Journal:  Clin Exp Immunol       Date:  1982-03       Impact factor: 4.330

6.  T lymphocyte line specific for thyroglobulin produces or vaccinates against autoimmune thyroiditis in mice.

Authors:  R Maron; R Zerubavel; A Friedman; I R Cohen
Journal:  J Immunol       Date:  1983-11       Impact factor: 5.422

7.  Cellular basis of the genetic control of immune responsiveness to murine thyroglobulin in mice.

Authors:  A O Vladutiu; N R Rose
Journal:  Cell Immunol       Date:  1975-05       Impact factor: 4.868

8.  Murine thyroiditis: importance of adjuvant and mouse strain for the induction of thyroid lesions.

Authors:  N R Rose; F J Twarog; A J Crowle
Journal:  J Immunol       Date:  1971-03       Impact factor: 5.422

9.  Immunization with antigen and interleukin 2 in vivo overcomes Ir gene low responsiveness.

Authors:  H Kawamura; S A Rosenberg; J A Berzofsky
Journal:  J Exp Med       Date:  1985-07-01       Impact factor: 14.307

10.  Induction of autoimmunity in good and poor responder mice with mouse thyroglobulin and lipopolysaccharide.

Authors:  P S Esquivel; N R Rose; Y C Kong
Journal:  J Exp Med       Date:  1977-05-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.